Loyal Great International

Loyal Great International appears to be a Hong Kong private limited company rather than a biotech or pharmaceutical developer. Publicly available records identify it as LOYAL GREAT INTERNATIONAL LIMITED (旺福國際有限公司), incorporated in Hong Kong on December 8, 2014, and currently listed as live/active in business-directory records. The main healthcare-related public footprint for the entity is an FDA/FTC warning letter issued in 2020 in connection with online marketing of unapproved products claiming to mitigate, prevent, treat, diagnose, or cure COVID-19 through the SuperHealthGuard website. There is no reliable evidence from public sources that the company operates a drug R&D pipeline, runs clinical trials, owns a therapeutic platform, or develops branded biotech/pharma assets. Based on currently available information, it is best characterized as a commercial company associated with online consumer health-product marketing rather than a life sciences innovator.